Medical Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . Medical Developments International
MVP Stock   0.42  0.01  2.44%   
Medical Developments financial statements provide useful quarterly and yearly information to potential Medical Developments International investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Medical Developments financial statements helps investors assess Medical Developments' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Medical Developments' valuation are summarized below:
Gross Profit
22.2 M
Profit Margin
(1.24)
Market Capitalization
47.3 M
Enterprise Value Revenue
1.2027
Revenue
33.1 M
There are currently ninety-one fundamental ratios for Medical Developments that can be evaluated and compared over time across peers in the industry. All traders should check Medical Developments' last-minute fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Medical Developments Total Revenue

34.81 Million

Check Medical Developments financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical Developments' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.6 M, Interest Expense of 78.2 K or Total Revenue of 34.8 M, as well as many indicators such as . Medical financial statements analysis is a perfect complement when working with Medical Developments Valuation or Volatility modules.
  
This module can also supplement various Medical Developments Technical models . Check out the analysis of Medical Developments Correlation against competitors.

Medical Developments Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets44.3 M59.2 M54.9 M
Slightly volatile
Short and Long Term Debt Total2.7 M2.3 M2.6 M
Very volatile
Total Current Liabilities5.1 M9.5 M6.5 M
Slightly volatile
Total Stockholder Equity28.2 M45.7 M33.5 M
Slightly volatile
Property Plant And Equipment Net10.7 M10.2 M6.7 M
Slightly volatile
Accounts Payable8.7 M8.3 M3.9 M
Slightly volatile
Cash7.9 M9.7 M10.4 M
Slightly volatile
Non Current Assets Total24.1 M33 M28.7 M
Slightly volatile
Cash And Short Term Investments7.9 M9.7 M10.4 M
Slightly volatile
Net Receivables7.4 M7.1 M4.5 M
Slightly volatile
Common Stock Total Equity49.5 M47.1 M26.2 M
Slightly volatile
Common Stock Shares Outstanding67.3 M88.6 M65.1 M
Slightly volatile
Short Term Investments200 K225 K245 K
Slightly volatile
Liabilities And Stockholders Equity44.6 M59.2 M55.4 M
Slightly volatile
Non Current Liabilities Total7.1 M3.9 M9.4 M
Slightly volatile
Inventory9.2 M8.8 M4.2 M
Slightly volatile
Other Current Assets482.6 K565 K612.8 K
Very volatile
Total Liabilities16.1 M13.4 M21.3 M
Slightly volatile
Property Plant And Equipment Gross23.8 M22.7 M10.1 M
Slightly volatile
Total Current Assets15.1 M26.1 M19.1 M
Slightly volatile
Short Term Debt494.4 K371 K679.6 K
Slightly volatile
Intangible Assets20 M19 M6.7 M
Slightly volatile
Common Stock127.7 M121.6 M45.5 M
Slightly volatile
Other Current Liabilities607 K639 K1.9 M
Pretty Stable
Other Liabilities2.4 M2.6 M10.5 M
Slightly volatile
Other Assets4.4 M4.6 M15.6 M
Slightly volatile
Good Will5.7 M3.4 M6.9 M
Slightly volatile
Property Plant Equipment14.6 M13.9 M7.2 M
Slightly volatile
Net Tangible Assets91.4 M87.1 M33.7 M
Slightly volatile
Deferred Long Term Liabilities24.5 M37.6 M20.6 M
Slightly volatile
Short and Long Term Debt77.8 K81.9 K1 M
Slightly volatile
Long Term Debt Total2.6 M2.5 M2 M
Slightly volatile
Non Current Liabilities Other22.4 M34.5 M20.9 M
Slightly volatile
Net Invested Capital54.1 M45.7 M38.6 M
Slightly volatile
Cash And Equivalents19.6 M28.4 M12.2 M
Slightly volatile
Net Working Capital22 M16.6 M14 M
Slightly volatile
Capital Stock81.9 M121.6 M57.8 M
Slightly volatile
Capital Lease Obligations2.2 M2.3 M3 M
Slightly volatile

Medical Developments Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.6 M3.4 M1.8 M
Slightly volatile
Total Revenue34.8 M33.1 M19.4 M
Slightly volatile
Other Operating Expenses52.5 M50 M23 M
Slightly volatile
Total Operating Expenses25.6 M24.4 M12 M
Slightly volatile
Selling General Administrative34.2 M32.5 M10.9 M
Slightly volatile
Selling And Marketing Expenses2.4 M2.8 M2.7 M
Slightly volatile
Cost Of Revenue7.4 M8.8 M8.7 M
Slightly volatile
Research Development195.6 K271.4 K235.3 K
Slightly volatile
Interest Income243.6 K402 K156.4 K
Slightly volatile
Reconciled Depreciation3.1 M3.4 M2.4 M
Slightly volatile

Medical Developments Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow25.9 M24.7 M11.2 M
Slightly volatile
Depreciation3.6 M3.4 M1.5 M
Slightly volatile
Capital Expenditures2.5 M3.2 M3.1 M
Slightly volatile
End Period Cash Flow8.2 M9.7 M10.5 M
Slightly volatile
Dividends Paid31.9 M30.3 M9.1 M
Slightly volatile
Stock Based Compensation1.5 M1.4 M550.6 K
Slightly volatile
Issuance Of Capital Stock20.4 M34.5 M23.1 M
Very volatile

Medical Fundamental Market Drivers

Forward Price Earnings166.6667
Cash And Short Term Investments9.7 M

About Medical Developments Financial Statements

Medical Developments shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Medical Developments investors may analyze each financial statement separately, they are all interrelated. The changes in Medical Developments' assets and liabilities, for example, are also reflected in the revenues and expenses on on Medical Developments' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue325.4 K508.4 K
Total Revenue33.1 M34.8 M
Cost Of Revenue8.8 M7.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Medical Stock Analysis

When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY